BD Veritor™

There's a life behind every test

A family sightseeing while traveling
Clock icon

Fast, Reliable Results

BD Veritor Plus Analyzer icon

Convenient Portability

Nasal sample icon

Simple Sample Collection

Computer screen icon

Easy Reporting Options

The BD Veritor™ Plus System offers convenient point-of-care testing for SARS-CoV-2*, Influenza A+B, Group A Streptococcus, and respiratory syncytial virus and combines rapid, reliable results with ease of implementation and simple workflow options.

Two ways to test

BD Veritor At-Home COVID-19 Test

Introducing the BD Veritor™ At-Home COVID-19 Test

Reliable, digitally read results so you can Veritor™ Test & Go back to living


No prescription or lab work needed—just digitally read, reliable COVID-19* test results you can trust in 15 minutes on your smartphone, from the comfort of home or convenience on the go.

BD Veritor Plus System

The BD Veritor™ Plus System


Convenient point-of-care testing

SARS-CoV-2*, Influenza A+B, Group A Streptococcus, and respiratory syncytial virus and combines rapid, reliable results with ease of implementation and simple workflow options.
 

The Value of Diagnostic Testing

Point-of-care rapid antigen testing

When a respiratory infection hits, results cannot be delayed. Rapid diagnostic testing plays a key role in informing healthcare professionals to make quick care decisions.

One system, multiple possibilities

The faster you know which infection is present, the faster you can respond.

The BD Veritor™ Plus System fits seamlessly into your workflow. The reliable, convenient system allows you to easily provide testing where and when it is needed, delivering rapid, informative results you can trust.

Articles and studies in multiple peer-reviewed publications including the New England Journal of Medicine1 and the British Medical Journal2 have touted the benefits of serial, rapid antigen testing. In addition, a recent landmark RADx-funded study demonstrated that the serial use of diagnostic tests (at least twice per week), including rapid antigen tests, increased the ability to detect infection3.  The BD Veritor™ System for the Rapid Detection of SARS-CoV-2* supports this approach in everyday locations such as schools and businesses, along with serial testing in other situations, such as athletes and teams to ensure safe games and competitions.

REFERENCES

  1. New England Journal of Medicine, November 26, 2020; 383:e120, DOI: 10.1056/NEJMp2025631
  2. BMJ 2021;372:n208
  3. https://www.medrxiv.org/content/10.1101/2021.03.19.21253964v2.full.pdf

** In patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation